Wellington Management Group
OLMA icon

Wellington Management Group’s Olema Pharmaceuticals OLMA Stock Holding History

Wellington Management Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.91M Buy
664,679
+443,708
+201% +$9.88M ﹤0.01% 1240
2025
Q4 		$5.52M Buy
220,971
+16,764
+8% +$298K ﹤0.01% 1392
2025
Q3 		$2M Sell
204,207
-23,814
-10% -$143K ﹤0.01% 1631
2025
Q2 		$971K Sell
228,021
-1,245,658
-85% -$5.55M ﹤0.01% 1730
2025
Q1 		$5.54M Sell
1,473,679
-51,805
-3% -$261K ﹤0.01% 1351
2024
Q4 		$8.84M Buy
1,525,484
+522,799
+52% +$5.22M ﹤0.01% 1228
2024
Q3 		$12M Buy
1,002,685
+97,428
+11% +$1.25M ﹤0.01% 1116
2024
Q2 		$9.79M Buy
905,257
+69,644
+8% +$755K ﹤0.01% 1156
2024
Q1 		$9.46M Buy
835,613
+736,200
+741% +$9.5M ﹤0.01% 1153
2023
Q4 		$1.39M Buy
99,413
+292
+0.3% +$3.92K ﹤0.01% 1561
2023
Q3 		$1.22M Buy
99,121
+38,011
+62% +$387K ﹤0.01% 1574
2023
Q2 		$552K Buy
+61,110
New +$369K ﹤0.01% 1677
2022
Q3 		– Sell
-275,984
Closed -$1.12M – 2117
2022
Q2 		$1.12M Sell
275,984
-712,055
-72% -$2.26M ﹤0.01% 1658
2022
Q1 		$4.21M Sell
988,039
-1,031,070
-51% -$5.68M ﹤0.01% 1434
2021
Q4 		$18.9M Buy
2,019,109
+369,905
+22% +$7.66M ﹤0.01% 1093
2021
Q3 		$45.5M Buy
1,649,204
+32,906
+2% +$888K 0.01% 841
2021
Q2 		$45.2M Sell
1,616,298
-398,917
-20% -$11.4M 0.01% 854
2021
Q1 		$66.1M Sell
2,015,215
-54,100
-3% -$2.32M 0.01% 730
2020
Q4 		$96.4M Buy
+2,069,315
New +$97M 0.02% 600

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Wellington Management Group's OLMA Position: Q1 2026 in Review

Wellington Management Group increased its Olema Pharmaceuticals (OLMA) stake by 201% in Q1 2026, buying an estimated $9.88M and bringing the position to 664,679 shares worth $9.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Wellington Management Group first reported a position in OLMA in Q4 2020 and has held it in 19 quarters since. The position peaked at $96.4M in Q4 2020. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Wellington Management Group held 664,679 shares of Olema Pharmaceuticals worth $9.91M as of Q1 2026.
  • Wellington Management Group bought 443,708 Olema Pharmaceuticals shares in Q1 2026, an estimated $9.88M.
  • Olema Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1240 holding.
  • Wellington Management Group first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 19 quarters since.
  • Wellington Management Group's Olema Pharmaceuticals position peaked at $96.4M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.